Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00183521 · ClinicalTrials.gov registry record · NA

Breathing Regulation Training for Individuals With Panic Disorder

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
136
Enrollment target

NCT00183521: Completed NA study, sponsored by Stanford University.

NCT00183521 is a NA study that has completed, run by Stanford University. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00183521, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target

Study Summary

This study will compare two different breathing regulation techniques to determine which is more effective in reducing the rate of panic attacks in people with panic disorder.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Raise-CO2 breathing regulation training
  • BEHAVIORAL Lower-CO2 breathing regulation training

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2005-03
Est. Completion 2008-11
Phase NA
Stanford University

1,744 total trials

What the finished NCT00183521 record still lists

NCT00183521 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.

NCT00183521 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00183521 about?

NCT00183521 is a clinical study titled "Breathing Regulation Training for Individuals With Panic Disorder". This study will compare two different breathing regulation techniques to determine which is more effective in reducing the rate of panic attacks in people with panic disorder.

What is the current status of trial NCT00183521?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2005-03. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00183521?

The interventions under investigation include: Control (BEHAVIORAL), Raise-CO2 breathing regulation training (BEHAVIORAL), Lower-CO2 breathing regulation training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00183521?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00183521's enrollment target sits among peer trials

136 722nd of 2000 higher than 1,275 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00183521, the US trial registry maintained by the National Library of Medicine. NCT00183521 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.